发明申请
US20100311053A1 USE OF CLEC1B FOR THE DETERMINATION OF CARDIOVASCULAR AND THROMBOTIC RISK
审中-公开
CLEC1B用于确定心血管和血栓风险的应用
- 专利标题： USE OF CLEC1B FOR THE DETERMINATION OF CARDIOVASCULAR AND THROMBOTIC RISK
- 专利标题（中）： CLEC1B用于确定心血管和血栓风险的应用
-
申请号： US12679547申请日： 2008-09-13
-
公开(公告)号： US20100311053A1公开(公告)日： 2010-12-09
- 发明人: Detlef Kozian , Peter Wonerow , Matthias Herrmann
- 申请人： Detlef Kozian , Peter Wonerow , Matthias Herrmann
- 申请人地址： FR Paris
- 专利权人： SANOFI-AVENTIS
- 当前专利权人： SANOFI-AVENTIS
- 当前专利权人地址： FR Paris
- 优先权： EP07291134.0 20070924
- 国际申请： PCT/EP2008/007593 WO 20080913
- 主分类号： C12Q1/68
- IPC分类号： C12Q1/68 ; G01N33/53 ; C07H21/04
摘要：
The use of the single nucleotide polymorphism (SNP) of the CLEC1B gene for the identification of cardiovascular and/or thrombotic disorders or of an increased risk for developing cardiovascular and/or thrombotic disorders in a biological sample taken from an individual to be examined; the use of CLEC1B for identifying substances active in preventing and/or treating cardiovascular and/or thrombotic disorders and methods for doing so.
信息查询
